You are using an outdated browser. We suggest you update your browser for a better experience. Click here for update.
Close this notification.
Skip to main content Skip to search

regorafenib

( RE-goe-RAF-e-nib )
Funding:
Exceptional Access Program
  • regorafenib - For the treatment of metastatic and/or unresectable gastrointestinal stromal tumors (GIST), according to specific criteria
  • For the treatment of hepatocellular carcinoma according to clinical criteria
Other Name(s): Stivarga®
Appearance: tablet

Patient Info Sheet

Oct 2017

What it is used for

For treating colorectal cancer, gastrointestinal stromal tumours (GIST) or liver cancer in patients who have received treatment(s) before. 



You might also be interested in